Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
For better or worse, advancements in tech are transforming our trips. We look at the developments and how they might shape ...
While taking a most pragmatic step, the Delhi High Court in a most learned, laudable, landmark, logical and latest judgment ...
The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...
Planet Rugby on MSN
Loose Pass: Courtroom shenanigans as ex-players hit ‘unedifying speed bump’ and last minute stocking fillers
"Those players affected continue to suffer, while clarity of information on head injury risks remains elusive." ...
Spain’s non-discrimination jurisprudence opens new tax refund possibilities for international taxpayers operating through ...
Social workers nationwide directed furious complaints toward their national association, demanding accountability, ...
Try a single issue or save on a subscription Issues delivered straight to your door or device Since the release of Demon's ...
There is a common misconception that AI applications can be sufficiently tested and derisked by running a pilot in a ...
Mark Helprin’s stories' and novels' surfaces glitter and shimmer and shine with snow and ice. Perhaps no living writer, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback